NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 21 filers reported holding NABRIVA THERAPEUTICS AG in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,133,000 | +93.2% | 677,710 | -4.1% | 1.93% | +23.1% |
| Q4 2016 | $4,210,000 | +2.3% | 706,383 | +21.1% | 1.57% | +1.4% |
| Q3 2016 | $4,114,000 | -1.8% | 583,521 | +4.4% | 1.54% | -23.3% |
| Q2 2016 | $4,191,000 | -14.2% | 558,771 | +2.5% | 2.01% | -26.3% |
| Q1 2016 | $4,883,000 | +23.0% | 544,972 | +32.0% | 2.73% | +43.8% |
| Q4 2015 | $3,971,000 | +19.0% | 412,747 | +17.5% | 1.90% | -1.7% |
| Q3 2015 | $3,337,000 | – | 351,261 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,151,700 | $22,219,000 | 6.92% |
| Omega Fund Management, LLC | 1,145,890 | $8,079,000 | 6.17% |
| ACUTA CAPITAL PARTNERS, LLC | 583,521 | $4,114,000 | 1.54% |
| EcoR1 Capital, LLC | 548,912 | $3,870,000 | 1.19% |
| Opaleye Management Inc. | 239,500 | $1,688,000 | 0.88% |
| Novo Holdings A/S | 1,116,660 | $7,872,000 | 0.70% |
| Boxer Capital, LLC | 176,710 | $1,246,000 | 0.56% |
| FT Options LLC | 58,055 | $414,000 | 0.33% |
| JACKSON PARK CAPITAL, LLC | 26,000 | $185,000 | 0.24% |
| Rock Springs Capital Management LP | 426,000 | $3,003,000 | 0.19% |